General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Part of paid clinical trials in Bemidji, Minnesota.
- Sponsor
- Sanford Health
- Study ID
- NCT04477928
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Minutes - 17 Years
- Healthy Volunteers
- Accepted
Interventions
- Sera and whole blood sampling — DIAGNOSTIC_TEST* Study Entry: Single Nucleotide Polymorphism (SNP)-Based Genetic Risk Score at study entry. * 2 years old: T1D autoantibodies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies * 5 years old: T1D and celiac autoantibodies * 9-16 year old: one-time T1D and celiac autoantibodies * Siblings of people with T1D autoimmunity, ages 6-17 years: one-time T1D and celiac autoantibodies
- Differential Gene Expression (DGE) — DIAGNOSTIC_TESTOpt-in: Differential Gene Expression from cord blood at birth and peripheral blood at 12 months of age
Study Details
In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.
Key Dates
- Start date
- Jul 17, 2020
- Status verified
- Feb 2026
- Primary completion
- Mar 31, 2031
- Completion
- Mar 31, 2031
Study Design
- Enrollment
- 33,000 participants (estimated)
Arms
- Arm: Study GroupChildren receiving routine care at a Sanford facility
Primary Outcome Measure
Demonstrated feasibility of large-scale population screening, as evidenced by: [ Time Frame: By year 10 of the study ]
Central Contacts
- Ann Mays, RN, CPN605-312-6052
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sanford Bemidji Region Clinics | Bemidji | Minnesota | 56601 | Kurt Griffin, PhD, MD (PRINCIPAL_INVESTIGATOR) |
| Sanford Bismarck Region Clinics | Bismarck | North Dakota | 58501 | Kurt Griffin, PhD, MD (PRINCIPAL_INVESTIGATOR) |
| Sanford Fargo Region Clinics | Fargo | North Dakota | 58112 | Kurt Griffin, PhD, MD (PRINCIPAL_INVESTIGATOR) |
| Sanford Sioux Falls Region Clinics | Sioux Falls | South Dakota | 57105 | Kurt Griffin, PhD, MD (PRINCIPAL_INVESTIGATOR) Sharon Hunt, BS, MS, MBA (SUB_INVESTIGATOR) Candice Nelson, MD, FAAP (SUB_INVESTIGATOR) Stephanie Hanson, MD, FAAP (SUB_INVESTIGATOR) Louis Casas, MD, FAAP (SUB_INVESTIGATOR) Brenda Thurlow, MD, FAAP (SUB_INVESTIGATOR) Kyle Baum, MD (SUB_INVESTIGATOR) Ann Mays, RN, CPN (SUB_INVESTIGATOR) |
Find similar trials in Bemidji, MN
By condition
By specialty
Related Studies
- TArgeting Type 1 Diabetes Using POLyamines (TADPOL)PHASE2 · Recruiting · Emily K. Sims · Aurora, Colorado
- Tissue Destruction and Healing in Celiac DiseaseRecruiting · University of Chicago · Pasadena, California
- Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes MellitusNot Yet Recruiting · Mayo Clinic · Rochester, Minnesota
- VTP-1000 in Adults With Celiac DiseaseEARLY_PHASE1 · Recruiting · Barinthus Biotherapeutics · Los Angeles, California